Brett Charlton

3.3k total citations
50 papers, 2.6k citations indexed

About

Brett Charlton is a scholar working on Genetics, Immunology and Surgery. According to data from OpenAlex, Brett Charlton has authored 50 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 19 papers in Immunology and 16 papers in Surgery. Recurrent topics in Brett Charlton's work include Diabetes and associated disorders (19 papers), Pancreatic function and diabetes (15 papers) and Cystic Fibrosis Research Advances (12 papers). Brett Charlton is often cited by papers focused on Diabetes and associated disorders (19 papers), Pancreatic function and diabetes (15 papers) and Cystic Fibrosis Research Advances (12 papers). Brett Charlton collaborates with scholars based in Australia, United States and United Kingdom. Brett Charlton's co-authors include T E Mandel, Kevin J. Lafferty, Robyn M. Slattery, Sandra D. Anderson, Akira Shimada, C. Garrison Fathman, Evangelia Daviskas, Anna Jaques, Emma E. Hamilton‐Williams and E. G. Gray and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Brett Charlton

50 papers receiving 2.5k citations

Peers

Countries citing papers authored by Brett Charlton

Since Specialization

Citations

This map shows the geographic impact of Brett Charlton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett Charlton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett Charlton more than expected).

Fields of papers citing papers by Brett Charlton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett Charlton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett Charlton. The network helps show where Brett Charlton may publish in the future.

Co-authorship network of co-authors of Brett Charlton

This figure shows the co-authorship network connecting the top 25 collaborators of Brett Charlton. A scholar is included among the top collaborators of Brett Charlton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett Charlton. Brett Charlton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Optimising inhaled mannitol for cystic fibrosis in an adult population 2015 ·Breathe ·Patrick A. Flume, Moira L. Aitken, Diana Bilton, Penny Agent, Brett Charlton, (unknown), (unknown), Helge Hebestreit, John Kolbe, Jonathan B. Zuckerman, Brenda Button	19
2	Inspiratory Flows and Volumes in Subjects with Cystic Fibrosis Using a New Dry Powder Inhaler Device 2014 ·The Open Respiratory Medicine Journal ·Mark R. Elkins, Philip Robinson, Sandra D. Anderson, Clare Perry, Evangelia Daviskas, Brett Charlton	17
3	Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial 2014 ·Thorax ·Diana Bilton, Gregory Tino, Alan F. Barker, Daniel C. Chambers, Anthony De Soyza, Lieven Dupont, (unknown), E.H.J. van Haren, Luis Otero Vidal, Tobias Welte, (unknown), (unknown), Brett Charlton	116
4	Inhaled mannitol for non-cystic fibrosis bronchiectasis - results of a 12 month, multi-centre, double-blind, controlled study 2013 ·European Respiratory Journal ·Diana Bilton, Gregory Tino, Alan R. Barker, Daniel C. Chambers, Anthony De Soyza, Lieven Dupont, (unknown), (unknown), Luis Otero Vidal, Tobias Welte, Howard Fox, Jian Wu, Brett Charlton	2
5	Phase 3 Randomized Study of the Efficacy and Safety of Inhaled Dry Powder Mannitol for the Symptomatic Treatment of Non-Cystic Fibrosis Bronchiectasis 2013 ·CHEST Journal ·Diana Bilton, Evangelia Daviskas, Sandra D. Anderson, John Kolbe, Gregory G. King, Rob G. Stirling, Bruce Thompson, David Milne, Brett Charlton	84
6	Pooled analysis of two large randomised phase III inhaled mannitol studies in cystic fibrosis 2012 ·Journal of Cystic Fibrosis ·Diana Bilton, G. Bellon, Brett Charlton, Peter Cooper, K. De Boeck, Patrick A. Flume, (unknown), Charles G. Gallagher, David E. Geller, Eric G. Haarman, Helge Hebestreit, John Kolbe, Allen Lapey, Philip Robinson, (unknown), Jonathan B. Zuckerman, Moira L. Aitken	50
7	Long-Term Inhaled Dry Powder Mannitol in Cystic Fibrosis: An International Randomized Study 2011 ·American Journal of Respiratory and Critical Care Medicine ·Moira L. Aitken, G. Bellon, K. De Boeck, Patrick A. Flume, (unknown), David E. Geller, Eric G. Haarman, Helge Hebestreit, Allen Lapey, (unknown), Jonathan B. Zuckerman, Brett Charlton	94
8	Inhaled mannitol in patients with cystic fibrosis: A randomised open-label dose response trial 2010 ·Journal of Cystic Fibrosis ·Alejandro Teper, Anna Jaques, Brett Charlton	39
9	Comparison of mannitol and methacholine to predict exercise-induced bronchoconstriction and a clinical diagnosis of asthma 2009 ·Respiratory Research ·(unknown), Sandra D. Anderson, Brett Charlton, John M. Weiler, Sara Nichols, Sheldon L. Spector, David S. Pearlman	126
10	Inhaled Mannitol Improves the Hydration and Surface Properties of Sputum in Patients With Cystic Fibrosis 2009 ·CHEST Journal ·Evangelia Daviskas, Sandra D. Anderson, Anna Jaques, Brett Charlton	61
11	Inhaled Mannitol Improves Lung Function in Cystic Fibrosis 2008 ·CHEST Journal ·Anna Jaques, Evangelia Daviskas, (unknown), Karen McKay, Peter Cooper, Rob G. Stirling, Colin Robertson, Peter T.P. Bye, Peter N. Le Souëf, Bruce Shadbolt, Sandra D. Anderson, Brett Charlton	117
12	The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline 2005 ·Respiratory Research ·John D. Brannan, Sandra D. Anderson, Clare Perry, (unknown), (unknown), Brett Charlton, (unknown)	168
13	Mechanisms of Accelerated Immune-Mediated Diabetes Resulting from Islet β Cell Expression of a Fas Ligand Transgene 2003 ·The Journal of Immunology ·Diego G. Silva, Nikolai Petrovsky, Luis Socha, Robyn M. Slattery, Paul A. Gatenby, Brett Charlton	24
14	Inhibition of Nitric Oxide Synthase Initiates Relapsing Remitting Experimental Autoimmune Encephalomyelitis in Rats, Yet Nitric Oxide Appears to be Essential for Clinical Expression of Disease 2001 ·The Journal of Immunology ·(unknown), Brett Charlton, William B. Cowden, David O. Willenborg	34
15	Nitric Oxide Plays a Critical Role in the Recovery of Lewis Rats from Experimental Autoimmune Encephalomyelitis and the Maintenance of Resistance to Reinduction 1999 ·The Journal of Immunology ·(unknown), Brett Charlton, William B. Cowden, David O. Willenborg	63
16	Monoclonal T Cells Identified in Early NOD Islet Infiltrates 1996 ·Immunity ·Yang Yang, Brett Charlton, Akira Shimada, (unknown), C. Garrison Fathman	58
17	Immune Regulation in Type 1 Diabetes 1996 ·Journal of Autoimmunity ·Akira Shimada, Brett Charlton, Patricia Rohane, Cariel Taylor-Edwards, Garrison C. Fathman	28
18	CD4+ T CELL MEDIATED DESTRUCTION OF XENOGRAFTS WITHIN CELL-IMPERMEABLE MEMBRANES IN THE ABSENCE OF CD8+ T CELLS AND B CELLS1 1996 ·Transplantation ·Thomas Loudovaris, T E Mandel, Brett Charlton	72
19	The Th1/Th2 balance in autoimmunity 1995 ·Current Opinion in Immunology ·Brett Charlton, Kevin J. Lafferty	184
20	Prevention of diabetes in non-obese diabetic I-Ak transgenic mice 1990 ·Nature ·Robyn M. Slattery, Lars Kjer‐Nielsen, Janette Allison, Brett Charlton, T E Mandel, J. F. A. P. Miller	162

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact